-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Lyell Immunopharma, Maintains $44 Price Target

Benzinga·05/07/2026 10:33:10
Listen to the news
Needham analyst Gil Blum reiterates Lyell Immunopharma (NASDAQ:LYEL) with a Buy and maintains $44 price target.